|
Just in case you missed our initial alert from yesterday we’re resending it to you again this morning. Start your research now before its too late!
--------------
Did you know that hearing aids cost on average, 25x more than your average computer? And did you know that the market for hearing aids and related products is worth more than $7 BLN in 2012 with projections of 8 Pct. CAGR up to 2016?
Welcome to one of the most dynamic and underrated industries you’ll come across in 2014 and welcome back!
I want to kick off this year in stunning form and believe my latest pick is just what the doctor ordered. Operating in the aforementioned multi-BLN dollar hearing aid industry, this company has charted a very lofty 2014 so far and is carrying forward some serious upward pressure.
2013 saw no less than 282 Pct. added to lower valuations and right now traders looked poised to grow market valuation even more.
How far can this gem go? Well to put things into perspective, a rival player that is listed on the NYSE is trading at $75 a share. No joke; hearing aids are making companies rich and you have lead-in that could kick-start your trading year with a bang.
Get ready to put away some dough on this one folks, 2014 is a go!
NEW Trade Alert: Hear AtLast Holdings, Inc. (OTCPINK: HRAL)
Investor Highlights
HRAL momentum profile couldn’t be more enticing. 20-day MA is up 54 Pct.; 50-day MA is up 67 Pct. and the short term 5-day MA is up a solid 67 Pct..
HRAL is attracting very bullish trading and this has pushed RSI to the 64 mark. But here’s the thing: the play isn’t overbought yet and with trading volume showing depth, now is the perfect time to dive in.
HRAL’s short term gain potential has been on display for well over a week. Rallies of 17 Pct., 15 Pct. and 30 Pct. look ready to give way to the telegraphed breakout so traders have to act quickly!!
HRAL has forged key strategic alliances with some of the biggest manufacturers and distributors of hearing aid equipment in the United States. The company counts Siemens and Walmart as strategic partners.
HRAL is operating in an industry which generated more than $7 BLN in 2012 and which is projected to see a CAGR of 7.7 Pct. over the next few years.
HRAL’s 23 operational hearing clinics across the U.S. have given it considerable market reach. The company’s ability shift hearing aids is very evident and with hearing retailing for up 7,000 USD a pair, growth potential is very strong.
About HRAL
HRAL (HearAtLast Holdings, Inc.) operates hearing clinics in North America.
HRAL offers hearing assessments and hearing instruments. Its products comprise digital hearing aid instruments and assistive-listening devices, as well as accessories, such as hearing aid wax guards, chargers, cleaners, sound tubes, etc.
HRAL has more than 23 hearing aid clinics within the Wal-Mart structure.
HRAL was founded in 2004 and is headquartered in Chicago, Illinois.
Hearings Aids – Dominating Healtcare Industry Sales Growth
All the talk about Obamcare being unworkable has overshadowed some of the more potentially lucrative aspects of U.S. healthcare. One such industry is hearing aids and as of 2013, hearing aids constitute one of the fastest growing areas of the Healthcare industry and the technology is evolving at an exponential rate. A decade or two ago, a hearing aid was just a hearing aid—but this is no longer the case.
Today’s selection of advanced and customized hearing aids is growing at an exponential rate, and resulting, so is the amount of revenue being brought in by the market as a whole. Indeed, as of 2012 The Global Hearing Aids Market is valued at $7.33 BLN and it’s set to continue growing at a CAGR of 7.17 percent for the 2012-2016 period.
Presently, BTE is the largest segment accounting for well over half of the Global Hearing Aids market in 2012. Nevertheless, as technology evolves making more advanced hearing aids more accessible to end-users, the shares of each segment are likely to shift around a bit.
For instance, demand for ITE hearing aids is expected to increase due to the release of invisible ITE hearing aids. The ITE segment captured around 15 percent of the Global Hearing Aids market in 2012, and is expected to witness a faster growth rate than the other segments during the forecast period. CIC hearing aids are also expected to capture market share from traditional BTE hearing aid manufacturers.
With this in mind, many vendors are expanding their product portfolios to include more than one hearing aid type while others are entering strategic mergers and acquisitions to extend their market reach. For instance, William Demant Holding acquired Oticon in 2009 after Oticon introduced the US FDA-approved Ponto bone-anchored implant system. Since then, the company has also acquired Grason Stadler, and Neurelec.
As is the case in any market, the more end-users who are happy, the more profitable the business—and when it comes to the Global Hearing Aid Market the key to fulfilling this aim, is offering a wide selection of advanced and high-quality products. The demand is there, and it’s up to vendors to rise to the challenge of meeting it!
Clearly the hearing aid industry is a very dynamic and burgeoning one; all the better therefore for a company like HRAL who is at the forefront of retail and dispensing.
Hearing Aid Clinics Industry Set for Rapid Growth (IBISWorld)
The Hearing Aid Clinics industry has contracted slightly during the past five years as declines in insurance coverage and consumer income combined with rising hearing aid prices. Following the financial crisis, a number of individuals were left “without private health insurance coverage as unemployment levels rose,” says IBISWorld analyst Austen Sherman.
“In addition, disposable income fell, leaving hearing aids as a luxury for a large number of those in need.” As a result, industry revenue declined from 2009 through 2011.
More recently, the Hearing Aid Clinics industry has returned to growth, says Sherman. “Employment levels have improved slightly and federal funding for health insurance programs has expanded in anticipation of healthcare reform.”
As a result, IBISWorld estimates industry revenue will rise 3.2 Pct. in 2013. Nevertheless, recent performance will be unable to overcome earlier losses, resulting in anticipated revenue decline of 0.2 Pct. per year on average to $2.0 BLN in 2013.
The past five years have exacerbated a broader trend of consolidation within the industry. The Hearing Aid Clinics industry's largest operators have always looked to purchase small nonemployers to expand their number of storefronts and increase their consumer exposure.
Declining revenue even forced some of the industry's largest operators to declare bankruptcy, making them prime targets for acquisitions. For example, a Siemens AG affiliate purchased HearUSA in 2011 after the latter filed bankruptcy.
Fortunately for the remaining operators in the industry, the consolidation has helped push profit margins slightly higher during the past five years.
During the next five years, the industry is expected to benefit largely from the implementation of the Patient Protection and Affordable Care Act; 32 MLN uninsured Americans are expected to gain coverage through 2019, according to the Congressional Budget Office.
In addition, the number of individuals suffering from hearing deficiencies is expected to remain high due to the expanding diabetes epidemic, the rising use of mobile music devices and headphones and the aging US population.
HRAL is a premier opportunity to kick-start your trading year. The underlying technical setup is robust and very bullish and fundamentally the company is built like a rock.
You really couldn’t ask for a better start so begin your due diligence right away.
For information on HRAL visit: http://www.hearatlastholdings.com/
|
